Syndromes and Congenital Heart Defects

Critical Heart Disease in Infants and Children

Volumn , Issue , 2006, Pages 951-971

  Murphy, Anne M ^a   Neill, Catherine A ^a   Zuckerberg, Aaron L ^b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c Division of Pediatric Anesthesiology and Critical Care Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 76749117474     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-032301281-2.50048-5     Document Type: Chapter

References (223)

1. Ahmed ML, Foot AB, Edge JA, et al. Noonan's syndrome: Abnormalities of the growth hormone/IGF-I axis and the response to treatment with human biosynthetic growth hormone. Acta Paediatr Scand 1991, 80:446-450.
2. Allanson JE, Hall JG, Hughes HE, et al. Noonan syndrome: The changing phenotype. Am J Med Genet 1995, 21:507-514.
3. Amann G, Sherman FS Myocardial dysgenesis with persistent sinusoids in a neonate with Noonan's phenotype. Pediatr Pathol 1992, 12:83-92.
4. American Academy of pediatrics Committee on Genetics Health supervision for children with Down syndrome. Pediatrics 1994, 93:855-859.
5. Antonelli D, Antonelli J, Rosenfeld T Noonan's syndrome associated with hypoplastic left heart. Cardiology 1990, 77:62-65.
6. Applegate KE, Goske MJ, Pierce G, Murphy D Situs revisited: Imaging of the heterotaxy syndrome. Radiographics 1990, 19:837-852. discussion 853-854.
7. Arenson EB, Forde MD Bone marrow transplantation for acute leukemia and Down syndrome: Report of a successful case and results of a national survey. J Pediatr 1989, 114:69-72.
8. Basson CT, Bachinsky DR, Lin RC, et al. Mutations in human TBX5 cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 1997, 15:30-35.
9. Batstone PJ, Faed MJ, Jung RT, Gosden J 45,X/46,X dic (Y) mosaicism in a phenotypic male. Arch Dis Child 1991, 66:252-253.
10. Beller FK, Zlatnik GP The beginning of human life: Medical observations and ethical reflections. Clin Obstet Gynecol 1992, 35:720-728.
11. Berdon WE, Baker DH Plain film findings in azygos continuation of the inferior vena cava. AJR Am J Roentgenol Radium Ther Nucl Med 1968, 104:452-457.
12. Bernier-Buzzanga J, Su WP Noonan's syndrome with extensive verrucae. Cutis 1990, 46:242-246.
13. Bierman FZ, Williams RG Subxiphoid two-dimensional imaging of the interatrial septum in infants and neonates with congenital heart disease. Circulation 1979, 60:80-90.
14. Biggar WD, Ramirez RA, Rose V Congenital asplenia: Immunologic assessment and a clinical review of eight surviving patients. Pediatrics 1981, 67:548-551.
15. Binder M The teratogenic effects of a bis-dichloroacetyl-diamine on hamster embryos: Aortic arch anomalies and the pathogenesis of the DiGeorge syndrome. Am J Pathol 1985, 118:179-193.
16. Brewster SF, Kennedy RH, Smith PJ A male pseudohermaphrodite with Noonan's syndrome. Br J Urol 1992, 69:96-97.
17. Bristow JD, Bernstein HS Counseling families with chromosome 22q11 deletions: The catch in CATCH-22. J Am Coll Cardiol 1998, 32:499-501.
18. Brown PM, Lewis GT, Parker AJ, Maw AR The skull base and nasopharynx in Down's syndrome in relation to hearing impairment. Clin Otolaryngol 1989, 14:241-246.
19. Burn J The aetiology of congenital heart disease. Paediatric Cardiology 1987, 15-63. Churchill Livingstone, Edinburgh. R.H. Anderson, F.J. Macartney, E.A. Shinebourne (Eds.).
20. Burn J Closing time for CATCH-22. J Med Genet 1999, 36:737-738.
21. Bush JA, Ainger LE Congenital absence of spleen with congenital heart disease: Report of a case with antemortem diagnosis on the basis of hematologic morphology. Pediatrics 1955, 15:93.
22. Bushby KM Recent advances in understanding muscular dystrophy. Arch Dis Child 1992, 67:1310-1312.
23. Campbell AM, Bousfield JD Anaesthesia in a patient with Noonan's syndrome and cardiomyopathy. Anaesthesia 1992, 47:131-133.
24. Campbell M, Deuchar DC Absent inferior vena cava, symmetrical liver, splenic agenesis, and situs inversus, and their embryology. Br Heart J 1967, 29:268-275.
25. Carey JC Health supervision and anticipatory guidance for children with genetic disorders (including specific recommendations for trisomy 21, trisomy 18, and neurofibromatosis I). Pediatr Clin North Am 1992, 39:25-53.
26. Cassidy R, Fleishman A Pediatric Ethics: From Principles to Practice 1996, Harwood, Amsterdam.
27. Chaimovitz C, Abinader E, Benderly A, Better OS Hypocalcemic hypotension. JAMA 1972, 222:86-87.
28. Chang AC Pediatric cardiac intensive care: Current state of the art and beyond the millennium. Curr Opin Pediatr 2000, 12:238-246.
29. Chen SC, deMello D Growth and development of lungs in siblings with nonimmune hydrops. Chest 1990, 97:1255-1257.
30. Clapp S, Perry BL, Farooki ZQ, et al. Down's syndrome, complete atrioventricular canal, and pulmonary vascular obstructive disease. J Thorac Cardiovasc Surg 1990, 100:115-121.
31. Clark EB, Takao A Overview: A focus for research in cardiovascular development. Developmental Cardiology: Morphogenesis and Function 1990, 3-12. Futura, NY. E.B. Clark, A. Takao (Eds.).
32. Clarke LA Mitochondrial disorders in pediatrics: Clinical, biochemical, and genetic implications. Pediatr Clin North Am 1992, 39:319-334.
33. Cohen MM, Gorlin RJ Noonan-like/multiple giant cell lesion syndrome. Am J Med Genet 1991, 40:159-166.
34. Cohen WI Atlantoaxial instability: What's next?. Arch Pediatr Adolesc Med 1998, 152:119-122.
35. Cooke RE Ethics in pediatric research. Pediatr Res 2000, 47:542.
36. Cooley WC, Graham JM Down syndrome: An update and review for the primary pediatrician. Clin Pediatr (Phila) 1991, 30:233-253.
37. Corsello G, Maresi E, Corrao AM, et al. VATER/VACTERL association: Clinical variability and expanding phenotype including laryngeal stenosis. Am J Med Genet 1992, 44:813-815.
38. Cremers CW, van der Burgt CJ Hearing loss in Noonan syndrome. Int J Pediatr Otorhinolaryngol 1992, 23:81-84.
39. Cullen S, Sharland GK, Allan LD, Sullivan ID Potential impact of population screening for prenatal diagnosis of congenital heart disease. Arch Dis Child 1992, 67:775-778.
40. Cuneo BF, Driscoll DA, Gidding SS, Langman CB Evolution of latent hypoparathyroidism in familial 22q11 deletion syndrome. Am J Med Genet 1997, 69:50-55.
41. Cuneo BF, Langman CB, Ilbawi MN, et al. Latent hypoparathyroidism in children with conotruncal cardiac defects. Circulation 1996, 93:1702-1708.
42. Cyran SE, Martinez R, Daniels S, et al. Spectrum of congenital heart disease in CHARGE association. J Pediatr 1987, 110:576-578.
43. de la Chapelle A, Herva R, Koivisto M, Aula P A deletion in chromosome 22 can cause DiGeorge syndrome. Hum Genet 1981, 57:253-256.
44. Deanfield JE, Leanage R, Stroobant J, et al. Use of high kilovoltage filtered beam radiographs for detection of bronchial situs in infants and young children. Br Heart J 1980, 44:577-583.
45. DeLeon SY, Gidding SS, Ilbawi MN, et al. Surgical management of infants with complex cardiac anomalies associated with reduced pulmonary blood flow and total anomalous pulmonary venous drainage. Ann Thorac Surg 1987, 43:207-211.
46. Dickinson DF, Wilkinson JL, Anderson KR, et al. The cardiac conduction system in situs ambiguus. Circulation 1979, 59:879-885.
47. Diekema DS, Shugerman RP An ethics curriculum for the pediatric residency program: Confronting barriers to implementation. Arch Pediatr Adolesc Med 1997, 151:609-614.
48. DiGeorge A Congenital absence of the thymus and its immunologic consequences: Concurrence with congenital hypoparathyroidism. Immunologic Deficiency Diseases in Man 1968, Vol IV:116-121. March of Dimes-Birth Defects Foundation, White Plains, NY. D. Bersma (Ed.).
49. Donnenfeld AE, Nazir MA, Sindoni F, Librizzi RJ Prenatal sonographic documentation of cystic hygroma regression in Noonan syndrome. Am J Med Genet 1991, 39:461-465.
50. Driscoll DA, Salvin J, Sellinger B, et al. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: Implications for genetic counselling and prenatal diagnosis. J Med Genet 1993, 30:813-817.
51. Duncan WJ, Fowler RS, Farkas LG, et al. A comprehensive scoring system for evaluating Noonan syndrome. Am J Med Genet 1981, 10:37-50.
52. Dupuis C, Charaf LA, Breviere GM, Abou P 'Infantile' form of the scimitar syndrome with pulmonary hypertension. Am J Cardiol 1993, 71:1326-1330.
53. Epstein CJ Down syndrome (trisomy 21). The Metabolic and Molecular Bases of Inherited Disease 2001, 1223-1256. McGraw-Hill, NY. C.R. Scriver, A.L. Beaudet, W.S. Sly (Eds.).
54. Evans DG, Lonsdale RN, Patton MA Cutaneous lymphangioma and amegakaryocytic thrombocytopenia in Noonan syndrome. Clin Genet 1991, 39:228-232.
55. Ewart AK, Jin W, Atkinson D, et al. Supravalvular aortic stenosis associated with a deletion disrupting the elastin gene. J Clin Invest 1994, 93:1071-1077.
56. Ewart AK, Morris CA, Atkinson D, et al. Hemizygosity at the elastin locus in a developmental disorder: Williams syndrome. Nat Genet 1993, 5:11-16.
57. Ferencz C, Neill CA Cardiovascular malformations: Prevalence at live birth. Neonatal Heart Disease 1992, 19-29. Springer Verlag, NY. R.M. Freedom, L.N. Benson, J.R. Smallhorn (Eds.).
58. Ferencz C, Neill CA, Boughman JA, et al. Congenital cardiovascular malformations associated with chromosome abnormalities: An epidemiologic study. J Pediatr 1989, 114:79-86.
59. Ferencz C, Rubin JD, Loffredo CA, Magee CA Epidemiology of congenital heart disease: The Baltimore-Washington Infant Study 1981-1989 1993, Futura Publishing, Mount Kisco, NY.
60. Ferencz C, Rubin JD, McCarter RJ, et al. Cardiac and noncardiac malformations: Observations in a population-based study. Teratology 1987, 35:367-378.
61. Flashburg MH, Dunbar BS, August G, Watson D Anesthesia for surgery in an infant with DiGeorge syndrome. Anesthesiology 1983, 58:479-481.
62. Flick JT, Singh AK, Kizer J, Lazarchick J Platelet dysfunction in Noonan's syndrome: A case with a platelet cyclooxygenase-like deficiency and chronic idiopathic thrombocytopenic purpura. Am J Clin Pathol 1991, 95:739-742.
63. Forrest SM, Smith TJ, Cross GS, et al. Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy. Lancet 1987, 2:1294-1297.
64. Fost N Ethical issues in genetics. Pediatr Clin North Am 1992, 39:79-89.
65. Fost N Introduction: Ethics, ethics everywhere. Curr Probl Pediatr 1992, 22:422-423.
66. Freeman SB, Taft LF, Dooley KJ, et al. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet 1998, 80:213-217.
67. Fryer AE, Holt PJ, Hughes HE The cardio-facio-cutaneous (CFC) syndrome and Noonan syndrome: Are they the same?. Am J Med Genet 1991, 38:548-551.
68. Fryns JP, Volcke P, Van den Berghe H The cardio-facio-cutaneous (CFC) syndrome: Autosomal dominant inheritance in a large family. Genet Couns 1992, 3:19-24.
69. Gabrielli O, Salvolini U, Coppa GV, et al. Magnetic resonance imaging in the malformative syndromes with mental retardation. Pediatr Radiol 1990, 21:16-19.
70. Gamallo C, Garcia M, Palacios J, Rodriguez JI Decrease in calcitonin-containing cells in truncus arteriosus. Am J Med Genet 1993, 46:149-153.
71. Garabedian M Hypocalcemia and chromosome 22q11 microdeletion. Genet Couns 1999, 10:389-394.
72. Gebbia M, Ferrero GB, Pilia G, et al. X-linked situs abnormalities result from mutations in ZIC3. Nat Genet 1997, 17:305-308.
73. Giles TD, Iteld BJ, Rives KL The cardiomyopathy of hypoparathyroidism: Another reversible form of heart muscle disease. Chest 1981, 79:225-229.
74. Goldmuntz E, Clark BJ, Mitchell LE, et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol 1998, 32:492-498.
75. Green MJ, Fost N Who should provide genetic education prior to gene testing? Computers and other methods for improving patient understanding. Genet Test 1997, 1:131-136.
76. Greenberg F, Elder FF, Haffner P, et al. Cytogenetic findings in a prospective series of patients with DiGeorge anomaly. Am J Hum Genet 1988, 43:605-611.
77. Grubben C, Fryns JP, Smeets E, Van den Berghe H Noonan phenotype in the basal cell nevus syndrome. Genet Couns 1991, 2:47-54.
78. Haddow JE, Palomaki GE, Knight GJ, et al. Prenatal screening for Down's syndrome with use of maternal serum markers [see comments]. N Engl J Med 1992, 327:588-593.
79. Hall JG, Levin J, Kuhn JP, et al. Thrombocytopenia with absent radius (TAR). Medicine (Baltimore) 1969, 48:411-439.
80. Harrington H Absence of the thymus gland. Lond Med Gaz 1829, 3:314.
81. Hattori M, Fujiyama A, Taylor TD, et al. The DNA sequence of human chromosome 21: The chromosome 21 mapping and sequencing consortium. Nature 2000, 405:311-319.
82. Hayes A, Batshaw ML Down syndrome. Pediatr Clin North Am 1993, 40:523-535.
83. Heller RM, Dorst JP, James AE, Rowe RD A useful sign in the recognition of azygos continuation of the inferior vena cava. Radiology 1971, 101:519-522.
84. Hishitani T, Ogawa K, Hoshino K, Nakamura Y Surgical ligation of anomalous hepatic vein in a case of heterotaxy syndrome with massive intrahepatic shunting after modified Fontan operation. Pediatr Cardiol 1999, 20:428-430.
85. Hortop J, Tsipouras P, Hanley JA, et al. Cardiovascular involvement in osteogenesis imperfecta. Circulation 1986, 73:54-61.
86. Huether CA, Haroldson K, Ellis PM, Ramsay CN Impact of prenatal diagnosis on revised livebirth prevalence estimates of Down syndrome in the Lothian region of Scotland, 1978-1992. Genet Epidemiol 1996, 13:367-375.
87. Huhta JC, Smallhorn JF, Macartney FJ Two dimensional echocardiographic diagnosis of situs. Br Heart J 1982, 48:97-108.
88. Huhta JC, Smallhorn JF, Macartney FJ, et al. Cross-sectional echocardiographic diagnosis of systemic venous return. Br Heart J 1982, 48:388-403.
89. Hunter A, Pinsky L An evaluation of the possible association of malignant hyperpyrexia with the Noonan syndrome using serum creatine phosphokinase levels. J Pediatr 1975, 86:412-415.
90. Hutchins GM, Moore GW, Lipford EH, et al. Asplenia and polysplenia malformation complexes explained by abnormal embryonic body curvature. Pathol Res Pract 1983, 177:60-76.
91. Hyman BT Down syndrome and Alzheimer disease. Prog Clin Biol Res 1992, 379:123-142.
92. Isaacs H, Savage N, Badenhorst M, Whistler T Acid maltase deficiency: A case study and review of the pathophysiological changes and proposed therapeutic measures. J Neurol Neurosurg Psychiatry 1986, 49:1011-1018.
93. Izquierdo L, Kushnir O, Sanchez D, et al. Prenatal diagnosis of Noonan's syndrome in a female infant with spontaneous resolution of cystic hygroma and hydrops. West J Med 1990, 152:418-421.
94. Jacobs IN, Gray RF, Todd NW Upper airway obstruction in children with Down syndrome. Arch Otolaryngol Head Neck Surg 1996, 122:945-950.
95. Johnson JD, Jennings R Hypocalcemia and cardiac arrhythmias. Am J Dis Child 1968, 115:373-376.
96. Johnson MC, Strauss AW, Dowton SB, et al. Deletion within chromosome 22 is common in patients with absent pulmonary valve syndrome. Am J Cardiol 1995, 76:66-69.
97. Kalwinsky DK, Raimondi SC, Bunin NJ, et al. Clinical and biological characteristics of acute lymphocytic leukemia in children with Down syndrome. Am J Med Genet Suppl 1990, 7:267-271.
98. Kan JS, White RI, Mitchell SE, Gardner TJ Percutaneous balloon valvuloplasty: A new method for treating congenital pulmonary-valve stenosis. N Engl J Med 1982, 307:540-542.
99. Karr SS, Brenner JI, Loffredo C, et al. Tetralogy of Fallot: The spectrum of severity in a regional study, 1981-1985. Am J Dis Child 1992, 146:121-124.
100. Katz S, Kravetz S Facial plastic surgery for persons with Down syndrome: Research findings and their professional and social implications. Am J Ment Retard 1989, 94:101-110. discussion 111-120.
101. Kelley RI, Hennekam RC The Smith-Lemli-Opitz syndrome. J Med Genet 2000, 37:321-335.
102. Khoury MJ, Cordero JF, Greenberg F, et al. A population study of the VACTERL association: Evidence for its etiologic heterogeneity. Pediatrics 1983, 71:815-820.
103. Kidd L Cardiorespiratory problems in children with Down syndrome. Down Syndrome: Advances in Medical Care 1992, 61-69. Wiley-Liss, NY. I.T. Lott, E.E. McCoy (Eds.).
104. Kirby ML, Gale TF, Stewart DE Neural crest cells contribute to normal aorticopulmonary septation. Science 1983, 220:1059-1061.
105. Kirby ML, Turnage KL, Hays BM Characterization of conotruncal malformations following ablation of 'cardiac' neural crest. Anat Rec 1985, 213:87-93.
106. Korenberg JR, Chen XN, Schipper R, et al. Down syndrome phenotypes: The consequences of chromosomal imbalance. Proc Natl Acad Sci U S A 1994, 91:4997-5001.
107. Korenberg JR, Kawashima H, Pulst SM, et al. Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype. Am J Hum Genet 1990, 47:236-246.
108. Korenberg JR, Pulst SM, Gerwehr S Advances in the understanding of chromosome 21 and Down syndrome. Down Syndrome: Advances in Medical Care 1992, 3-12. Wiley-Liss, NY. I.T. Lott, E.E. McCoy (Eds.).
109. Kraynack NC, Hostoffer RW, Robin NH Agenesis of the corpus callosum associated with DiGeorge-velocardiofacial syndrome: A case report and review of the literature. J Child Neurol 1999, 14:754-756.
110. Kurnit DM, Aldridge JF, Matsuoka R, Matthysse S Increased adhesiveness of trisomy 21 cells and atrioventricular canal malformations in Down syndrome: A stochastic model. Am J Med Genet 1985, 20:385-399.
111. Landwirth J Ethical issues in pediatric and neonatal resuscitation. Ann Emerg Med 1993, 22:502-507.
112. Leana-Cox J, Pangkanon S, Eanet KR, et al. Familial DiGeorge/velocardiofacial syndrome with deletions of chromosome area 22q11.2: Report of five families with a review of the literature. Am J Med Genet 1996, 65:309-316.
113. Legius E, Schollen E, Matthijs G, Fryns JP Fine mapping of Noonan/cardio-facio cutaneous syndrome in a large family. Eur J Hum Genet 1998, 6:32-37.
114. Levy J The gastrointestinal tract in Down syndrome. Prog Clin Biol Res 1991, 373:245-256.
115. Lindsay EA, Goldberg R, Jurecic V, et al. Velo-cardio-facial syndrome: Frequency and extent of 22q11 deletions. Am J Med Genet 1995, 57:514-522.
116. Lobdell D Congenital absence of the parathyroid glands. Arch Pathol 1959, 67:412-415.
117. Lynch DR, McDonald-McGinn DM, Zackai EH, et al. Cerebellar atrophy in a patient with velocardiofacial syndrome [see comments]. J Med Genet 1995, 32:561-563.
118. Mahoney MJ, Hobbins JC Prenatal diagnosis of chondroectodermal dysplasia (Ellis-van Creveld syndrome) with fetoscopy and ultrasound. N Engl J Med 1977, 297:258-260.
119. Mantzouranis EC, Rosen FS, Colten HR Reticuloendothelial clearance in cystic fibrosis and other inflammatory lung diseases. N Engl J Med 1988, 319:338-343.
120. Marino B, Papa M, Guccione P, et al. Ventricular septal defect in Down syndrome. Anatomic types and associated malformations. Am J Dis Child 1990, 144:544-545.
121. Maron BJ, Moller JH, Seidman CE, et al. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: Hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome: A statement for healthcare professionals from the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association. Circulation 1998, 98:1460-1471.
122. Martin G Observations on d'une anomalie dans la situation dans la configuration du coeur et des vaisseaux qui en partnet ou qui s'y redent. Bulletin Soc Anat Paris 1826, 3:39-43.
123. Mathew P, Moodie D, Sterba R, et al. Long-term follow-up of children with Down syndrome with cardiac lesions. Clin Pediatr (Phila) 1990, 29:569-574.
124. Matsuoka R, Kimura M, Scambler PJ, et al. Molecular and clinical study of 183 patients with conotruncal anomaly face syndrome. Hum Genet 1998, 103:70-80.
125. Maximilian C, Ioan DM, Fryns JP A syndrome of mental retardation, short stature, craniofacial anomalies with palpebral ptosis, and pulmonary stenosis in three siblings with normal parents: An example of autosomal recessive inheritance of the Noonan phenotype?. Genet Couns 1992, 3:115-118.
126. McDonald-McGinn DM, Driscoll DA, et al. Detection of a 22q11.2 deletion in cardiac patients suggests a risk for velopharyngeal incompetence. Pediatrics 1997, 99:E9.
127. McDonald-McGinn DM, LaRossa D, Goldmuntz E, et al. The 22q11.2 deletion: Screening, diagnostic workup, and outcome of results: Report on 181 patients. Genet Test 1997, 1:99-108.
128. McKusick VA Mendelian Inheritance in Man. A Catalog of Human Genes and Genetic Disorders 1998, 3. Johns Hopkins University Press, Baltimore.
129. McKusick VA Online Mendelian Inheritance in Man 2000, Johns Hopkins University, Baltimore.
130. Mendez HM, Opitz JM Noonan syndrome: A review. Am J Med Genet 1985, 21:493-506.
131. Merscher S, Funke B, Epstein JA, et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 2001, 104:619-629.
132. Mitnick RJ, Bello JA, Shprintzen RJ Brain anomalies in velo-cardio-facial syndrome. Am J Med Genet 1994, 54:100-106.
133. Miyabara S Cardiovascular malformations of mouse trisomy 21. Developmental Cardiology: Morphogenesis and Function 1990, 409-430. Futura Publishing, NY. E.B. Clark, A. Takao (Eds.).
134. Momma K, Linde LM Abnormal P wave axis in congenital heart disease associated with asplenia and polysplenia. J Electrocardiol 1969, 2:395-402.
135. Monaco G, Pignata C, Rossi E, et al. DiGeorge anomaly associated with 10p deletion. Am J Med Genet 1991, 39:215-216.
136. Morris CD, Magilke D, Reller M Down's syndrome affects results of surgical correction of complete atrioventricular canal. Pediatr Cardiol 1992, 13:80-84.
137. Mueller RF The Alagille syndrome (arteriohepatic dysplasia). J Med Genet 1987, 24:621-626.
138. Murphy KC, Jones LA, Owen MJ High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999, 56:940-945.
139. Nair M, Kaul UA, Prasad R, et al. Successful percutaneous pulmonary balloon valvuloplasty in Noonan's syndrome: A case report. Indian Heart J 1990, 42:123-125.
140. Natowicz M, Chatten J, Clancy R, et al. Genetic disorders and major extracardiac anomalies associated with the hypoplastic left heart syndrome. Pediatrics 1988, 82:698-706.
141. Neill CA Congenital cardiac malformations and syndromes. Genetics of Cardiovascular Disease 1986, 95-112. Martinus-Nijhoff, Boston. M.E. Pierpont, J.H. Moller (Eds.).
142. Neill CA Genetics and recurrence risks of congenital heart disease. Fetal and Neonatal Cardiology 1989, 125-133. WB Saunders, Philadelphia. W.A. Long (Ed.).
143. Neill CA, Clark EB, Clark C The Heart of a Child 2001, Johns Hopkins University Press, Baltimore.
144. Neill CA, Ferencz C, Sabiston DC, Sheldon H The familial occurrence of hypoplastic right lung with systemic arterial supply and venous drainage 'Scimitar Syndrome.'. Bull Johns Hopkins Hosp 1960, 107:1-21.
145. Noonan JA Hypertelorism with Turner phenotype: A new syndrome with associated congenital heart disease. Am J Dis Child 1968, 116:373-380.
146. Noonan JA Noonan syndrome revisited. J Pediatr 1999, 135:667-668.
147. Noonan JA, Ehmke DA Associated noncardiac malformations in children with congenital heart disease. J Pediatr 1963, 63:468-470.
148. Olsen CL, Cross PK, Gensburg LJ, Hughes JP The effects of prenatal diagnosis, population ageing, and changing fertility rates on the live birth prevalence of Down syndrome in New York State, 1983-1992. Prenat Diagn 1996, 16:991-1002.
149. Opitz JM The developmental field concept. Am J Med Genet 1985, 21:1-11.
150. Oster G, Kilburn KH, Siegal FP Chemically induced congenital thymic dysgenesis in the rat: A model of the DiGeorge syndrome. Clin Immunol Immunopathol 1983, 28:128-134.
151. Papolos DF, Faedda GL, Veit S, et al. Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: Does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?. Am J Psychiatry 1996, 153:1541-1547.
152. Pastakia B, Lieberman LM, Moodie D, Levy J 99mTechnetium pyridoxylidene glutamate imaging in visceral heterotaxy (Ivemark's syndrome). Gastroenterology 1979, 77:1105-1108.
153. Paterson A, Frush DP, Donnelly LF, et al. A pattern-oriented approach to splenic imaging in infants and children. Radiographics 1999, 19:1465-1485.
154. Payne RM, Johnson MC, Grant JW, Strauss AW Toward a molecular understanding of congenital heart disease. Circulation 1995, 91:494-504.
155. Peck AL Aristotle: Historica Animalium. Book II 1965, 132. Harvard University Press, Cambridge.
156. Peoples WM, Moller JH, Edwards JE Polysplenia: A review of 146 cases. Pediatr Cardiol 1983, 4:129-137.
157. Pexieder T Teratogens. The Genetics of Cardiovascular Disease 1986, 25-68. Martinus-Nijhoff, Boston. M.E. Pierpont, J.E. Moller (Eds.).
158. Phoon CK, Neill CA Asplenia syndrome: Insight into embryology through an analysis of cardiac and extracardiac anomalies. Am J Cardiol 1994, 73:581-587.
159. Polhemus D, Schafer WB Congenital absence of the spleen: Syndrome, with atrioventricularis and situs inversus. Pediatrics 1952, 9:696-708.
160. Polhemus DW, Schafer W Absent spleen syndrome: Hematologic findings as aid to diagnosis. Pediatrics 1959, 24:254.
161. Pongratz G, Friedrich M, Unverdorben M, et al. Hypertrophic obstructive cardiomyopathy as a manifestation of a cardiocutaneous syndrome (Noonan syndrome). Klin Wochenschr 1991, 69:932-936.
162. Pueschel SM Should children with Down syndrome be screened for atlantoaxial instability?. Arch Pediatr Adolesc Med 1998, 152:123-125.
163. Pueschel SM, Scola FH, Tupper TB, Pezzullo JC Skeletal anomalies of the upper cervical spine in children with Down syndrome. J Pediatr Orthop 1990, 10:607-611.
164. Putschar WGJ, Manion WC Congenital absence of the spleen and associated anomalies. Am J Clin Pathol 1952, 26:429-470.
165. Radford DJ, Thong YH The association between immunodeficiency and congenital heart disease. Pediatr Cardiol 1988, 9:103-108.
166. Ranke MB, Heidemann P, Knupfer C, et al. Noonan syndrome: Growth and clinical manifestations in 144 cases. Eur J Pediatr 1988, 148:220-227.
167. Reeves RH, Irving NG, Moran TH, et al. A mouse model for Down syndrome exhibits learning and behaviour deficits [see comments]. Nat Genet 1995, 11:177-184.
168. Reller MD, Morris CD Is Down syndrome a risk factor for poor outcome after repair of congenital heart defects?. J Pediatr 1998, 132:738-741.
169. Roberts DJ, Genest D Cardiac histologic pathology characteristic of trisomies 13 and 21. Hum Pathol 1992, 23:1130-1140.
170. Rollnick BR Oculoauriculovertebral anomaly: Variability and causal heterogeneity. Am J Med Genet Suppl 1988, 4:41-53.
171. Rollnick BR, Kaye CI Hemifacial microstomia and variants: Pedigree data. Am J Med Genet 1983, 15:233-253.
172. Rose V, Izukawa T, Moes CA Syndromes of asplenia and polysplenia: A review of cardiac and non-cardiac malformations in 60 cases with special reference to diagnosis and prognosis. Br Heart J 1975, 37:840-852.
173. Rosemberg S, Carneiro PC, Zerbini MC, Gonzalez CH Brief clinical report: Chondroectodermal dysplasia (Ellis-van Creveld) with anomalies of CNS and urinary tract. Am J Med Genet 1983, 15:291-295.
174. Ruscazio M, Van Praagh S, Marrass AR, et al. Interrupted inferior vena cava in asplenia syndrome and a review of the hereditary patterns of visceral situs abnormalities. Am J Cardiol 1998, 81:111-116.
175. Ryan AK, Goodship JA, Wilson DI, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: A European collaborative study. J Med Genet 1997, 34:798-804.
176. Ryan CA, Finer NN, Ives E Discordance of signs in monozygotic twins concordant for the Goldenhaar anomaly. Am J Med Genet 1988, 29:755-761.
177. Schneider DS, Zahka KG, Clark EB, Neill CA Patterns of cardiac care in infants with Down syndrome. Am J Dis Child 1989, 143:363-365.
178. Schon F, Bowler J, Baraitser M Cerebral arteriovenous malformation in Noonan's syndrome. Postgrad Med J 1992, 68:37-40.
179. Schwartz N, Eisenkraft JB Anesthetic management of a child with Noonan's syndrome and idiopathic hypertrophic subaortic stenosis. Anesth Analg 1992, 74:464-646.
180. Seidman CE, Seidman JG Molecular genetic studies of familial hypertrophic cardiomyopathy. Basic Res Cardiol 1998, 93:13-16.
181. Sharland M, Burch M, McKenna WM, Paton MA A clinical study of Noonan syndrome. Arch Dis Child 1992, 67:178-183.
182. Sharland M, Patton MA, Talbot S, et al. Coagulation-factor deficiencies and abnormal bleeding in Noonan's syndrome. Lancet 1992, 339:19-21.
183. Sharland M, Taylor R, Patton MA, Jeffery S Absence of linkage of Noonan syndrome to the neurofibromatosis type 1 locus. J Med Genet 1992, 29:188-190.
184. Shimizu T, Takao A, Ando M, Hirayama A Conotruncal anomaly face syndrome: Its heterogeneity and association with thymus involution. Congenital Heart Diseases: Causes and Processes 1984, 29-41. Futura, NY. J.J. Nora, A. Takao (Eds.).
185. Shprintzen RJ, Goldberg RB, Lewin ML, et al. A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: Velo-cardio-facial syndrome. Cleft Palate J 1978, 15:56-62.
186. Shprintzen RJ, Goldberg RB, Young D, Wolford L The velo-cardio-facial syndrome: A clinical and genetic analysis. Pediatrics 1981, 67:167-172.
187. Shub C, Dimopoulos IN, Seward JB, et al. Sensitivity of two-dimensional echocardiography in the direct visualization of atrial septal defect utilizing the subcostal approach: Experience with 154 patients. J Am Coll Cardiol 1983, 2:127-135.
188. Smith AT, Sack GH, Taylor GJ Holt-Oram syndrome. J Pediatr 1979, 95:538-543.
189. Smith CA, Driscoll DA, Emanuel BS, et al. Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Diagn Lab Immunol 1998, 5:415-417.
190. Snider AR, Silverman NH Suprasternal notch echocardiography: A two-dimensional technique for evaluating congenital heart disease. Circulation 1981, 63:165-173.
191. Sonesson SE, Fouron JC, Lessard M Intrauterine diagnosis and evolution of a cardiomyopathy in a fetus with Noonan's syndrome. Acta Paediatr 1992, 81:368-370.
192. Stanger P, Cassidy SC, Girod DA, et al. Balloon pulmonary valvuloplasty: Results of the Valvuloplasty and Angioplasty of Congenital Anomalies Registry. Am J Cardiol 1990, 65:775-783.
193. Stebbens VA, Dennis J, Samuels MP, et al. Sleep related upper airway obstruction in a cohort with Down's syndrome. Arch Dis Child 1991, 66:1333-1338.
194. Stern HJ, Saal HM, Lee JS, et al. Clinical variability of type 1 neurofibromatosis: Is there a neurofibromatosis-Noonan syndrome?. J Med Genet 1992, 29:184-187.
195. Sty JR, Conway JJ The spleen: Development and functional evaluation. Semin Nucl Med 1985, 15:276-298.
196. Sullivan KE, Jawad AF, Randall P, et al. Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes. Clin Immunol Immunopathol 1998, 86:141-146.
197. Sykes KS, Bachrach LK, Siegel-Bartelt J, et al. Velocardiofacial syndrome presenting as hypocalcemia in early adolescence. Arch Pediatr Adolesc Med 1997, 151:745-747.
198. Takao A, Ando M, Cho K, et al. Etiologic categorization of common congenital heart disease. Etiology and Morphogenesis of Congenital Heart Disease 1980, 253-269. Futura, NY. R. Van Praagh, A. Takao (Eds.).
199. Tartaglia M, Mehler EL, Goldberg R, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 2001, 29:465-468.
200. Tosti A, Misciali C, Borrello P, et al. A loose anagen hair in a child with Noonan's syndrome. Dermatologica 1991, 182:247-249.
201. Traub A, Giebink GS, Smith C, et al. Splenic reticuloendothelial function after splenectomy, spleen repair, and spleen autotransplantation. N Engl J Med 1987, 317:1559-1564.
202. Tredwell SJ, Newman DE, Lockitch G Instability of the upper cervical spine in Down syndrome. J Pediatr Orthop 1990, 10:602-606.
203. Tubman TR, Shields MD, Craig BG, et al. Congenital heart disease in Down's syndrome: Two year prospective early screening study. BMJ 1991, 302:1425-1427.
204. Uemura H, Ho SY, Anderson RH, Yagihara T Ventricular morphology and coronary arterial anatomy in hearts with isometric atrial appendages. Ann Thorac Surg 1999, 67:1403-1411.
205. Ugazio AG, Maccario R, Notarangelo LD, Burgio GR Immunology of Down syndrome: A review. Am J Med Genet Suppl 1990, 7:204-212.
206. Van Mierop L, Gessner IH, Schiebler GL Asplenia and polysplenia syndrome. Birth Defect: Original Article Series 1972, 5:36-44.
207. Van Mierop LHS, Wigelsworth FW Isomerism of congenital asplenia with isomerism of the cardiac atria and sinoatrial nodes. Am J Cardiol 1964, 13:407.
208. Van Praagh S, Kreutzer J, Alday L, Van Praagh R Systemic and pulmonary venous connections in visceral heterotaxy, with emphasis on the diagnosis of the atrial situs: A study of 109 postmortem cases. Developmental Cardiology: Morphogenesis and Function 1990, 671-727. Futura, Mount Kisco, NY. E.B. Clark, A. Takao (Eds.).
209. Van Praagh S, Santini F, Sanders SP Cardiac malpositions with special emphasis on visceral heterotaxy (asplenia and polysplenia syndromes). Nadas' Pediatric Cardiology 1992, 589-608. Mosby-Year Book, Baltimore. D.C. Fyler (Ed.).
210. Veatch R Medical Ethics 1997, Jones & Bartlett, Boston.
211. Vigild M Dental caries experience among children with Down's syndrome. J Ment Defic Res 1986, 30:271-276.
212. Waldman JD, Rosenthal A, Smith AL, et al. Sepsis and congenital asplenia. J Pediatr 1977, 90:555-559.
213. Wassif CA, Maslen C, Kachilele-Linjewile S, et al. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. Am J Hum Genet 1988, 63:55-62.
214. Wilson DI, Burn J, Scambler P, Goodship J DiGeorge syndrome: Part of CATCH-22. J Med Genet 1993, 30:852-856.
215. Wilson DI, Cross IE, Wren C Minimum prevalence of chromosome 22q11 deletions. Am J Hum Genet 1994, 55:A169.
216. Wong CK, Cheng CH, Lau CP, Leung WH Congenital coronary artery anomalies in Noonan's syndrome. Am Heart J 1990, 119:396-400.
217. Wren C, Macartney FJ, Deanfield JE Cardiac rhythm in atrial isomerism. Am J Cardiol 1987, 59:1156-1158.
218. Yen BM, Schneiderman LJ Impact of pediatric ethics consultations on patients, families, social workers, and physicians. J Perinatol 1999, 19:373-378.
219. Yost HJ The genetics of midline and cardiac laterality defects. Curr Opin Cardiol 1998, 13:185-189.
220. Zahka KG, Spector M, Hanisch D Hypoplastic left-heart syndrome: Norwood operation, transplantation, or compassionate care. Clin Perinatol 1993, 20:145-154.
221. Zaloga GP Hypocalcemia in critically ill patients. Crit Care Med 1992, 20:251-262.
222. Zipursky A, Poon A, Doyle J Hematologic and oncologic disorders in Down syndrome. Down Syndrome: Advances in Medical Care 1992, 3-12. Wiley-Liss, NY. I.T. Lott, E.E. McCoy (Eds.).
223. Zori RT, Boyar FZ, Williams WN, et al. Prevalence of 22q11 region deletions in patients with velopharyngeal insufficiency. Am J Med Genet 1998, 77:8-11.